CEFTRIAXONE REDUCED SUSCEPTIBLE NEISSERIA GONORRHOEAE IN THE NETHERLANDS, 2009-2017: FROM PENA MOSAICISM TO A501T/V NON-MOSAICISM.
To compare molecular and epidemiological differences between ceftriaxone reduced susceptible (CRO-RS) and ceftriaxone susceptible (CRO-S) Neisseria gonorrhoeae (Ng), and to study the genetic relatedness of CRO-RS isolates. Demographic and clinical data, and samples for cultures were routinely collected from gonorrhoea patients visiting the Amsterdam STI clinic in 2009-2017. NG-MAST and penA types were compared between CRO-RS and CRO-S Ng (frequency matched on year of isolation and sexual risk group). Minimum spanning trees (MST) were produced based on NG-MLVA genotypes. We selected 174 CRO-RS isolates (MIC ≥0.064 mg/L) and 174 CRO-S isolates (MIC ≤0.016 mg/L). Demographic and clinical characteristics of patients were overall comparable between those infected with CRO-RS Ng and CRO-S Ng. However, CRO-RS isolates were more often collected from the pharyngeal site (OR 3.64, P <0.001), and patients with CRO-RS Ng were less often HIV and syphilis positive (OR 0.63, P=0.041 and OR 0.58, P=0.028 respectively). We identified 12 clusters based on NG-MLVA genotypes, including 3 large (>25 isolates) clusters predominantly containing CRO-RS isolates. Those from cluster 1 (n=32) were mostly from 2009-2012 (n=24; 75.0%), with a mosaic penA XXXIV pattern (n=27; 84.4%) and belonging to NG-MAST genogroup G1407 (n=24; 75.0%). Isolates from cluster 2 (n=29) were mostly from 2013-2015 (n=24; 82.7%), had a non-mosaic penA IX + A501T mutation (n=22; 75.9%) and NG-MAST G2400 (n=14; 48.3%). Most isolates from cluster 3 (n=37) were from 2015-2017 (n=26; 70.2%), had a non-mosaic penA IV + A501V mutation (n=24; 64.9%) and NG-MAST G2318 (n=22; 59.5%). We observed a shift in the predominant penA (from mosaic towards non-mosaic plus A501T/V mutation), NG-MAST and NG-MLVA types among CRO-RS Ng over time. This indicates a successive spread of different CRO-RS Ng clones.